David Sven Floren
@Dcf Advisers, Llc
Latest period2024 - Q3ReportedManaged Assets$250.177MTotal holdings82
Assets growth rate28.87%Assets growth rate (2-Q avg)12.25%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Dcf Advisers, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 82 positions.
Assets under management
The assets under management (AUM) of Dcf Advisers, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 250.177M in assets, with a quarterly growth rate of 28.87% and a 2-quarter average growth rate of 12.25%. The portfolio is managed by David Sven Floren, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
PFEPfizer Inc
| 0.4% | $994,089 34,350 shares@ $28.94 avg price | Decreased -2.55% |
OIO-i Glass Inc
| 0.39% | $974,160 74,250 shares@ $13.12 avg price | Decreased -18.18% |
MRVLMarvell Technology Inc
| 0.37% | $901,500 12,500 shares@ $72.12 avg price | Decreased -28.57% |
PYPLPaypal Holdings Inc
| 0.32% | $780,300 10,000 shares@ $78.03 avg price | Decreased -9.09% |
BABoeing Co
| 0.26% | $630,966 4,150 shares@ $152.04 avg price | Decreased -10.75% |
FLUTFlutter Entmt Plc
| 0.24% | $593,200 2,500 shares@ $237.28 avg price | Decreased -21.87% |
ALTAltimmune Inc
| 0.24% | $582,490 94,868 shares@ $6.15 avg price | Decreased -37.11% |
VRDNViridian Therapeutics Inc
| 0.14% | $329,875 14,500 shares@ $22.75 avg price | Decreased -18.3% |
1924⤦Coherus Biosciences Inc
| 0.11% | $274,750 350,000 shares@ $0.79 avg price | Decreased -74.07% |
TAt&t Inc
| 0.09% | $224,400 10,200 shares@ $22.0 avg price | Decreased -78.61% |